Answers are grounded in this paper and cite their sources.
Patients with cerebral ischemic stroke (CIS) are susceptible to acute kidney injury (AKI) during intensive care unit (ICU) hospitalization. The stress hyperglycemia ratio (SHR) reflects acute elevations in blood glucose relative to pre-morbid glycemic status; however, its association with AKI among critically ill CIS patients remains to be further clarified. To explore the association between SHR and the likelihood of AKI development in critically ill CIS patients. This retrospective cohort analysis was derived from the MIMIC-IV database and included critically ill CIS patients admitted to the ICU. We examine the association between SHR and AKI among critically ill CIS patients through multivariate logistic regression and restricted cubic spline (RCS) analyses. Subgroup analysis was conducted to assess population heterogeneity. Receiver operating characteristic (ROC) curve analysis was used to exploratorily evaluate the discriminatory performance of SHR for AKI. A total of 1086 critically ill CIS ICU‑admitted patients were included, of whom 279 (25.7%) developed AKI. Logistic regression analysis showed that, in Model 2, each 0.1-unit increase in SHR was associated with higher odds of AKI (OR = 1.113, 95%CI: 1.054–1.176, p < 0.001). No significant nonlinear association was detected ( p ‑non‑linear=0.312), and no significant interaction was observed across subgroups ( p for interaction > 0.05). After further adjustment for covariates related to disease severity, the effect estimate for the association between SHR and AKI in Model 3 was attenuated (OR = 1.062, 95% CI: 1.002–1.124, p = 0.041). After further inclusion of early treatment variables following ICU admission (Model 4), the direction of the association remained consistent, but it was no longer statistically significant (OR = 1.059, 95% CI: 0.998–1.123, p = 0.057). ROC analysis suggested that SHR alone had limited discriminatory capacity for AKI in this patient cohort. This study observed an association between elevated SHR and increased likelihood of AKI among critically ill CIS patients. However, the association was attenuated after adjustment for disease severity-related variables and was no longer statistically significant after further adjustment for early treatment factors. SHR also exhibited limited discriminatory performance for AKI when used alone. These findings suggest that SHR may provide tentative reference information for AKI risk assessment, but do not support its use as an independent screening tool. The potential clinical value of SHR requires further verification.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: